Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-75,118
Closed -$26.2K 671
2025
Q3
$26.2K Hold
75,118
﹤0.01% 613
2025
Q2
$34K Hold
75,118
﹤0.01% 582
2025
Q1
$30.6K Hold
75,118
﹤0.01% 578
2024
Q4
$49.7K Sell
75,118
-596
-0.8% -$414 ﹤0.01% 563
2024
Q3
$64.3K Buy
75,714
+596
+0.8% +$456 ﹤0.01% 567
2024
Q2
$50.1K Hold
75,118
﹤0.01% 552
2024
Q1
$97.7K Hold
75,118
﹤0.01% 583
2023
Q4
$43K Hold
75,118
﹤0.01% 556
2023
Q3
$56.6K Hold
75,118
﹤0.01% 548
2023
Q2
$54.8K Buy
+75,118
New +$69.8K ﹤0.01% 571

Other funds holding VXRT

HBK Sorce Advisory's VXRT Position: Q4 2025 in Review

HBK Sorce Advisory sold out of Vaxart (VXRT) in Q4 2025, closing a stake of 75,118 shares — an estimated $26.2K sold.

HBK Sorce Advisory first reported a position in VXRT in Q2 2023 and held it in 10 quarters. The position peaked at $97.7K in Q1 2024. 5 funds tracked by Wall St. Rank hold VXRT as of Q4 2025.

  • HBK Sorce Advisory reported no remaining Vaxart position as of Q4 2025 after selling out during the quarter.
  • HBK Sorce Advisory sold 75,118 Vaxart shares in Q4 2025, an estimated $26.2K.
  • HBK Sorce Advisory first reported a position in Vaxart in Q2 2023 and held it in 10 quarters.
  • HBK Sorce Advisory's Vaxart position peaked at $97.7K in Q1 2024.
  • 5 funds tracked by Wall St. Rank held Vaxart as of Q4 2025.

Based on HBK Sorce Advisory's 13F filing for Q4 2025, filed 9 Feb 2026.